Inventor
XUE TONGTONG
CN12 patents
⚠️ This page may combine multiple inventors who share the name “XUE TONGTONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD
11 patentsUS11136413B2Oct 5, 2021
PDL-1 antibody, pharmaceutical composition thereof, and uses thereof
SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD1 citations61
US10465014B2Nov 5, 2019
PDL-1 antibody, pharmaceutical composition thereof, and uses thereof
SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD1 citations61
US12297265B2May 13, 2025
Antibody and use thereof
SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD1 citations60
US12150944B2Nov 26, 2024
Use of anti-HER2 antibody-drug conjugate in cancer treatment
SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD0 citations59
US11970506B2Apr 30, 2024
Bioactive molecule conjugate, preparation method and use thereof
SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD0 citations59
US12258419B2Mar 25, 2025
Anti-FXI/FXIa antibody and use thereof
SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD1 citations58
US11207420B2Dec 28, 2021
Cytotoxin and conjugate, uses of same and preparation method therefor
SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD0 citations58
US11655295B2May 23, 2023
Anti-LAG-3 antibody and use thereof
SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD0 citations50
US12269816B2Apr 8, 2025
Benzothiophene compound, preparation method therefor and use thereof
SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD0 citations49
US11903948B2Feb 20, 2024
Anti-ErbB2 antibody-drug conjugate and composition thereof, preparation method therefor, and use thereof
SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD0 citations48
US11421029B2Aug 23, 2022
Recombinant bispecific antibodies to PD-L1 and CTLA-4
SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD0 citations44